2021 highlights Pivot Park Community
Read here a short summary of the 2021 highlights of our Community members
3 January 2022
Menu
2021 highlights Pivot Park Community
Read here a short summary of the 2021 highlights of our Community members
Synergy between biopharma and academia
Pivot Park firmly believes in the importance of collaboration between biotech and academia, and therefore strongly supports its partners with its broad “knowledge network”, which includes the Institute for Complex Molecular Systems (ICMS) at the Eindhoven University of Technology (TU/e).
Bioconnection: GMP certification for new large scale filling line
BioConnection received from the Dutch Healthcare Inspectorate (IGJ) the GMP certification and manufacturing license for their new large scale filling line
InProcess-LSP and DIANT Pharma Inc. finalize Partnership Agreement
Inprocess LSP is expanding its capabilities as a true PAT solutions provider through a partnership agreement between InProcess-LSP and Diant Pharma Inc. for continuous manufacturing of liposomes and lipid nanoparticles in drug delivery applications such as Covid 19 vaccines manufacturing.
Bioconnection: successful connection with the whole world from Oss
In the Brabant Impact Monitor, Alexander Willemse talks about the connection between drug developers and drug manufacturers.
De buren maken levensgrote muurschildering op de blauwe wand
Oss mag stemmen over muurschildering
Lots of opportunities for medicine innovation in the Netherlands
An impressive report of the strengths and importance of the Life Science & Health sector for our collective well-being.
Vivenics and Tenwise join forces for new Dotmatics applications
In this collaboration, Vivenics will integrate the TenWise KMAP platform for literature mining into the Dotmatics platform
RiboPro raises €1.2M to become leader in (m)RNA
RiboPro announced it has successfully closed a funding round of €1.2 million, led by Stichting Vlasroot
ELF paper selected for print in a special issue of SLAS Discovery
European Lead Factory: Experiences and Output from Assay Development and Ultra-High-Throughput Screening.
2020 highlights Pivot Park Community
Read here a short summary of the 2020 highlights of our Community members
or call
Pivot Park – Building RK
Kloosterstraat 9
5349 AB Oss
The Netherlands
+31 (0)412 – 84 60 10
info@pivotpark.com
Pivot Park Exploitatie B.V.
Building OP
Kloosterstraat 9
5349 AB Oss
The Netherlands
10 years ago, Pivot Park opened its doors to the world. Thanks to your commitment, support and confidence, we have been able to grow it into the successful and innovative biopharmaceutical campus it is today.
We are therefore delighted to invite you – along with all your fellow CEOs at Pivot Park – to a special night out featuring inspiring art, a wonderful dinner and lots of opportunities to network and exchange ideas.
The development of medicines in Oss began one hundred years ago. It was then that the foundations were laid for what would become a flourishing pharmaceutical sector in the Netherlands, leading to groundbreaking discoveries such as insulin and the anti-conception pill.
Today, the entire chain is still represented in Oss, from early-stage research to the commercial scale production of medicines. Working in Oss, we focus on the health of people all over the world. Employees at dozens of companies large and small put their heart and soul into new medicines, products and services that will improve lives worldwide. Together, our strength lies in our combination of broad knowledge about the development of medicines and a thorough understanding of the requirements of high-quality production.
This shared past and common values stimulate strong bonds among everyone who works in pharmaceuticals in Oss. We build on qualities, expertise and networks that go back decades. And with a wide variety of pharmaceutical companies, suppliers and scientific institutions all located nearby, we offer an attractive business climate and an excellent basis for international collaboration.
We are proud to work together to create a better and healthier future for all, a collaboration that in turn fuels growing employment: today, most pharmaceutical jobs in the Netherlands are in Oss. Here we connect talent and companies and stimulate entrepreneurship, while our expert employees are our most important asset. Their drive ensures that Oss has an influence on health all over the world.
Pharma in Oss offers endless opportunities to startups and talent in a city and region that is a joy to live and work in. We are committed to collaboration and sustainable and successful entrepreneurship. Oss’s pharmaceutical companies are intrinsically competitive while also being committed to quality and safety. This, plus their focus on new health solutions and contemporary technology, makes us a leader in our pursuit of a better life for people worldwide.